Cytokinetics shares owned by Eventide Asset Management
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Eventide Asset Management
from 13F filings
Historical chart of Eventide Asset Management investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Cytokinetics by Eventide Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $9.3M | 170k | 54.96 |
| 2025-06-30 | $8.2M | 250k | 33.04 |
| 2025-03-31 | $15M | 383k | 40.19 |
| 2024-12-31 | $12M | 254k | 47.04 |
| 2024-09-30 | $13M | 254k | 52.80 |
| 2024-06-30 | $14M | 254k | 54.18 |
| 2024-03-31 | $18M | 254k | 70.11 |
| 2023-12-31 | $46M | 556k | 83.49 |
| 2023-09-30 | $16M | 556k | 29.46 |
| 2023-06-30 | $18M | 556k | 32.62 |
| 2023-03-31 | $20M | 556k | 35.19 |
| 2022-12-31 | $26M | 556k | 45.82 |